Media Contact:
Stephen Majors
Vice President, Global Communications
smajors@alliancerm.org
Washington, DC
Advancing value-based payment arrangements for cell and gene therapy has been a long-standing priority for ARM, and we view this as a step in the right direction to promoting access to cell and gene therapies for the Medicaid patients that need them.
Washington, DC
As the global voice of the cell and gene therapy sector, ARM believes courts lack the technical expertise to second-guess the FDA’s scientific and medical judgment.
Washington, DC
The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the engineered cell therapy and genetic medicines sector, announced the appointment of Rita Johnson-Greene as Chief Operating Officer, effective April 10.
Washington, DC
